NO20044050L - Fremgangsmate for syntese av chirale N-aryl-piperaziner - Google Patents
Fremgangsmate for syntese av chirale N-aryl-piperazinerInfo
- Publication number
- NO20044050L NO20044050L NO20044050A NO20044050A NO20044050L NO 20044050 L NO20044050 L NO 20044050L NO 20044050 A NO20044050 A NO 20044050A NO 20044050 A NO20044050 A NO 20044050A NO 20044050 L NO20044050 L NO 20044050L
- Authority
- NO
- Norway
- Prior art keywords
- piperazines
- chiral
- aryl
- synthesis
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36343102P | 2002-03-12 | 2002-03-12 | |
| PCT/US2003/007078 WO2003078417A1 (en) | 2002-03-12 | 2003-03-10 | Process for synthesizing chiral n-aryl piperazines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20044050L true NO20044050L (no) | 2004-09-24 |
Family
ID=28041762
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20044050A NO20044050L (no) | 2002-03-12 | 2004-09-24 | Fremgangsmate for syntese av chirale N-aryl-piperaziner |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6713626B2 (xx) |
| EP (1) | EP1483255B1 (xx) |
| JP (1) | JP4391241B2 (xx) |
| KR (1) | KR20040105765A (xx) |
| CN (2) | CN1304388C (xx) |
| AR (1) | AR038930A1 (xx) |
| AT (1) | ATE439356T1 (xx) |
| AU (1) | AU2003220094B2 (xx) |
| BR (1) | BR0308377A (xx) |
| CA (1) | CA2477892C (xx) |
| CR (1) | CR7431A (xx) |
| DE (1) | DE60328756D1 (xx) |
| EC (1) | ECSP045290A (xx) |
| ES (1) | ES2329122T3 (xx) |
| IL (1) | IL163827A0 (xx) |
| MX (1) | MXPA04008729A (xx) |
| NO (1) | NO20044050L (xx) |
| NZ (1) | NZ535168A (xx) |
| RU (1) | RU2315762C2 (xx) |
| TW (1) | TW200403231A (xx) |
| UA (1) | UA79273C2 (xx) |
| WO (1) | WO2003078417A1 (xx) |
| ZA (1) | ZA200408202B (xx) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060223824A1 (en) * | 2000-11-28 | 2006-10-05 | Wyeth | Serotonergic agents |
| US20060287335A1 (en) * | 2000-11-28 | 2006-12-21 | Wyeth | Serotonergic agents for treating sexual dysfunction |
| US7504395B2 (en) * | 2001-07-20 | 2009-03-17 | Psychogenics, Inc. | Treatment for attention-deficit hyperactivity disorder |
| ATE449073T1 (de) * | 2002-03-12 | 2009-12-15 | Wyeth Corp | Verfahren zur herstellung von n1-(2-pyridyl)-1,2- propandiaminsulfamidsäure und ihre verwendung zur herstellung von biologisch aktiven piperazinen |
| US7361773B2 (en) | 2002-03-12 | 2008-04-22 | Wyeth | Preparation of N1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines |
| US7091349B2 (en) * | 2002-03-12 | 2006-08-15 | Wyeth | Process for synthesizing N-aryl piperazines with chiral N′-1-[benzoyl(2-pyridyl)amino]-2-propane substitution |
| IL163828A0 (en) * | 2002-03-12 | 2005-12-18 | Wyeth Corp | Process for making chiral 1,4-disubstituted piperazines |
| US20050215561A1 (en) * | 2004-03-19 | 2005-09-29 | Krishnendu Ghosh | Pharmaceutical dosage forms and compositions |
| US20070099931A1 (en) * | 2004-03-19 | 2007-05-03 | Wyeth | Pharmaceutical dosage forms and compositions |
| PA8626301A1 (es) * | 2004-03-19 | 2006-12-07 | Wyeth Wyeth | Proceso para preparar derivados de n-aril-piperazina |
| JP2008531694A (ja) * | 2005-03-01 | 2008-08-14 | ワイス | 結晶性および非晶性４−シアノ−ｎ−｛（２ｒ）−２−［４−（２，３−ジヒドロ−ベンゾ［１，４］ジオキシン−５−イル）−ピペラジン−１−イル］−プロピル｝−ｎ−ピリジン−２−イル−ベンズアミド塩酸塩 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE81975T1 (de) | 1984-12-21 | 1992-11-15 | Duphar Int Res | Arzneimittel mit psychotroper wirkung. |
| JPH01125357A (ja) | 1987-11-06 | 1989-05-17 | Dainippon Pharmaceut Co Ltd | トリペプチドの誘導体 |
| MX9201991A (es) * | 1991-05-02 | 1992-11-01 | Jonh Wyeth & Brother Limited | Derivados de piperazina y procedimiento para su preparacion. |
| WO1994024115A1 (en) * | 1993-04-16 | 1994-10-27 | Santen Pharmaceutical Co., Ltd. | Novel piperazine derivative |
| DK0763024T3 (da) | 1994-06-03 | 2002-12-02 | Wyeth John & Brother Ltd | Fremgangmåde og mellemprodukter til fremstilling af piperazinderivater |
| GB9411099D0 (en) * | 1994-06-03 | 1994-07-27 | Wyeth John & Brother Ltd | Piperazine derivatives |
| GB9413772D0 (en) * | 1994-07-08 | 1994-08-24 | Wyeth John & Brother Ltd | 5-HT1A ligands |
| GB9514901D0 (en) * | 1995-07-20 | 1995-09-20 | American Home Prod | Piperazine derivatives |
| JP2000508319A (ja) | 1996-04-10 | 2000-07-04 | メルク エンド カンパニー インコーポレーテッド | αｖβ３拮抗薬 |
| US6469007B2 (en) | 2000-11-28 | 2002-10-22 | Wyeth | Serotonergic agents |
-
2003
- 2003-03-10 CA CA2477892A patent/CA2477892C/en not_active Expired - Fee Related
- 2003-03-10 MX MXPA04008729A patent/MXPA04008729A/es active IP Right Grant
- 2003-03-10 CN CNB038058413A patent/CN1304388C/zh not_active Expired - Fee Related
- 2003-03-10 US US10/384,845 patent/US6713626B2/en not_active Expired - Fee Related
- 2003-03-10 JP JP2003576423A patent/JP4391241B2/ja not_active Expired - Fee Related
- 2003-03-10 RU RU2004130300/04A patent/RU2315762C2/ru not_active IP Right Cessation
- 2003-03-10 BR BR0308377-2A patent/BR0308377A/pt not_active IP Right Cessation
- 2003-03-10 WO PCT/US2003/007078 patent/WO2003078417A1/en active Application Filing
- 2003-03-10 ES ES03716384T patent/ES2329122T3/es not_active Expired - Lifetime
- 2003-03-10 IL IL16382703A patent/IL163827A0/xx unknown
- 2003-03-10 NZ NZ535168A patent/NZ535168A/xx unknown
- 2003-03-10 CN CNA2007100083292A patent/CN1982307A/zh active Pending
- 2003-03-10 KR KR10-2004-7014156A patent/KR20040105765A/ko not_active Application Discontinuation
- 2003-03-10 TW TW092105097A patent/TW200403231A/zh unknown
- 2003-03-10 AU AU2003220094A patent/AU2003220094B2/en not_active Expired - Fee Related
- 2003-03-10 DE DE60328756T patent/DE60328756D1/de not_active Expired - Lifetime
- 2003-03-10 AT AT03716384T patent/ATE439356T1/de not_active IP Right Cessation
- 2003-03-10 EP EP03716384A patent/EP1483255B1/en not_active Expired - Lifetime
- 2003-03-11 AR ARP030100831A patent/AR038930A1/es unknown
- 2003-10-03 UA UA20041008211A patent/UA79273C2/uk unknown
-
2004
- 2004-08-24 CR CR7431A patent/CR7431A/es not_active Application Discontinuation
- 2004-09-10 EC EC2004005290A patent/ECSP045290A/es unknown
- 2004-09-24 NO NO20044050A patent/NO20044050L/no not_active Application Discontinuation
- 2004-10-11 ZA ZA200408202A patent/ZA200408202B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2315762C2 (ru) | 2008-01-27 |
| ES2329122T3 (es) | 2009-11-23 |
| KR20040105765A (ko) | 2004-12-16 |
| NZ535168A (en) | 2006-03-31 |
| AU2003220094B2 (en) | 2009-04-23 |
| ATE439356T1 (de) | 2009-08-15 |
| CA2477892C (en) | 2010-11-23 |
| CR7431A (es) | 2008-07-29 |
| AR038930A1 (es) | 2005-02-02 |
| AU2003220094A1 (en) | 2003-09-29 |
| TW200403231A (en) | 2004-03-01 |
| EP1483255A1 (en) | 2004-12-08 |
| ECSP045290A (es) | 2004-10-26 |
| US6713626B2 (en) | 2004-03-30 |
| US20030187265A1 (en) | 2003-10-02 |
| CN1982307A (zh) | 2007-06-20 |
| EP1483255B1 (en) | 2009-08-12 |
| JP2005526775A (ja) | 2005-09-08 |
| BR0308377A (pt) | 2005-01-11 |
| ZA200408202B (en) | 2007-03-28 |
| WO2003078417A1 (en) | 2003-09-25 |
| DE60328756D1 (de) | 2009-09-24 |
| JP4391241B2 (ja) | 2009-12-24 |
| CN1642936A (zh) | 2005-07-20 |
| IL163827A0 (en) | 2005-12-18 |
| MXPA04008729A (es) | 2005-07-13 |
| CA2477892A1 (en) | 2003-09-25 |
| CN1304388C (zh) | 2007-03-14 |
| UA79273C2 (en) | 2007-06-11 |
| RU2004130300A (ru) | 2005-04-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20043345L (no) | Fremgangsmate for fremstilling av hydrokarboner | |
| NO20034285D0 (no) | Fremgangsmåte for fremstilling av syntesegass | |
| CY2015015I1 (el) | Παραγωγη τιακουμυκινης | |
| NO20053796D0 (no) | Process for the production of particles | |
| IS7834A (is) | Aðferð til nýmyndunar á bensímídasólefnasambandi | |
| HRP20050360A2 (en) | Novel method for the industrial synthesis of the m | |
| NO20043586L (no) | Fremgangsmate for fremstilling av organiske forbindelser | |
| NO20044814L (no) | Fremgangsmate for fremstilling av combretastaniner | |
| NO20041182L (no) | Fremgangsmate for fremstilling av silisium | |
| ZA200602149B (en) | Process for the synthesis of 6-amino-4-[(3-chloro-4-fluo-rophenyl)amino]-7-ethoxy-quinoline-3-carbonitrile | |
| NO20033408D0 (no) | Fremgangsmåte for fremstilling av krystallinske nanopartikler | |
| NO20044050L (no) | Fremgangsmate for syntese av chirale N-aryl-piperaziner | |
| NO20050885D0 (no) | Ny fremgangsmate for syntesen av 1,3-dihydro-2H-3-benzazepin-2-onforbindelser, og anvendelse i syntesen av ivabradin og addisjonssalter derav med en farmasoytisk akseptabel syre | |
| NO20041850L (no) | Fremgangsmate for dannelse av profenkrystaller | |
| NO20034597L (no) | Fremgangsmate for fremstilling av cantaxantin | |
| ITMI20020933A0 (it) | Procedimento per la sintesi di clopidogrel | |
| NO20041224L (no) | Fremgangsmate for fremstilling av hydrokarboner | |
| NO20043760L (no) | Fremgangsmate til fremstilling av olefiner | |
| NO20043988L (no) | Fremgangsmate for fremstilling av chirale 1,4-substituerte piperaziner | |
| DK1511724T3 (da) | Fremgangsmåde til fremstilling af thioalkylaminderivater | |
| AU2003242867A8 (en) | Process for the synthesis of mosapride | |
| NO20052392L (no) | Fremgangsmate for fremstilling av acetylenforbindelser. | |
| EG24122A (en) | Process for the synthesis of 3-cyano-6-alkoxy-7-nitro-4-quinolines | |
| ITMI20020934A0 (it) | Processo per la sintesi di benazepril cloridrato | |
| AU2003270143A8 (en) | Improved methods for the synthesis of nucleic acids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |